JRI JRI
Company Profile ↓Company Overview
JRI (JRI) is a publicly traded company listed on with a market capitalization of $297.73M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 6.1.
Maintains a net profit margin of 97.5%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $50.38M (+82.8% YoY); net profit $49.11M.
- Trailing 12 Months Year-on-year growth — revenue +82.8%, earnings +92.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 82.76% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 92.54% |
Stock Price Performance
| 1 Year: | -12.73% |
| 6 Months: | -10.93% |
| 3 Months: | -13.78% |
| 1 Month: | -2.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)47.88 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 97.5%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | -71.62M | 34.39M | 27.57M | 50.38M |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 2.05M | 1.59M | 2.06M | 1.27M |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 4.36M | 9.24M | 9.24M | 8.60M |
| Pretax Income | -73.67M | 32.80M | 25.51M | 49.11M |
| Tax Provision | - | - | - | - |
| Net Income | -73.67M | 32.80M | 25.51M | 49.11M |
| Diluted EPS | -2.66 | 1.19 | 0.92 | 1.76 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 547.24M | 534.21M | 549.99M | 543.60M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 323.05K | 244.59K | 2.13M | 889.78K |
| Inventory | - | - | - | - | - |
| Receivables | - | 7.45M | 4.76M | 5.06M | 4.97M |
| Total Liabilities | - | 174.79M | 158.89M | 188.49M | 176.60M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 167.04M | 153.74M | 183.02M | 174.13M |
| Total Equity | - | 372.45M | 375.32M | 361.50M | 367.00M |
| Shares Outstanding | - | 27.71M | 27.67M | 27.67M | 27.70M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 54.54M | 44.78M | 14.17M | 52.64M |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | -57.60M | -44.86M | -12.28M | -53.73M |
| Capital Expenditure | - | - | - | - |
| Free Cash Flow | 54.54M | 44.78M | 14.17M | 52.64M |
| Net Change in Cash | -3.06M | -78.46K | 1.88M | -1.09M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 102.9% | 95.4% | 92.5% | 97.5% |
| ROE % | -19.8% | 8.7% | 7.1% | 13.4% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for JRI
Precision Trading with Nuveen Real Asset Income And Growth Fund Of Beneficial Interest (JRI) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxNazJFcUNvRlZxSzh0OHhZTzh0Nl85eUFOU0FBREJfbE9VWURjNWNqb3VtR0JjUWh4VzVOTFFtQk5QY0pDZG92T2p3ckZCV3ROcnNyclM0T0RzMlR6NjdrbHdwZjRNT0VVUjFSaU5fWnZ3a2w5cWpDR0RTeUpOakF5c2I4a2I3MFBZZ1FCem…
JRI: Could Be Good For Diversification, But Distribution Sustainability Is Uncertain (JRI) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNVHlUQUdxaXo5RHhrNFpGYlRtSVZYNHJWUTVIb3BESWczM2VCcThvNUxVUXdKWHpYR3NMOFFiYTgxcGhRbHBVMlNPT3l1T2tlRVpDczhlYl9IajFWMnVhZ0tpZGhjOTNOTnJCdDJyem5vNVBJZElNdTVkMmliS3FLZTEzVnlhZkN0SEZyU0…
Nuveen Real Asset Income and Growth Fund (JRI) Inches Higher as Consolidation Continues - Put Support - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxOa0tYZlgyNDV0YTZOX3hPUmdtSkZNSEh6bWVUd1NMUUh2X1pMQ2JlM3BjSmNyRFFnSkMweHNwVXpNbE9yQXdpNFlWU2pNSmhYLVZiZVBMNU5saTJzZjRrUC04VmNWWkdaREs0cS1FaWhrZ0trV2UzVEtVa3g0emF3MDRPdm1ReFNaV0QyTm…
Nuveen Real Asset Income and Growth Fund (JRI) Closes Flat at $10.77 as Traders Eye Range Boundaries - Buffered ETF - https://www.siam.in/
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxQd2ZubHBmTTdlMC1pVWpYck5RM3kwSGFxdDZUdXB0NFpDOUdST2o0cERPeENBdzcxV250bW0zYXM3OENFbnZKaS1FZ3NJNzZVQ2s4TjRod2tjQlNUektiaVJvMVZaNTVNbVB3WU5RQ0dQLXNtT3dXSmtTblBwbTZad091N2NQeE5LenVvRn…
ITAT Mumbai Nullifies Penny Stock Reassessment For Being Time-Barred Under TOLA - TaxCorp AI
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOcmd5cTVzZ3lIYmM2ank3MUUtSDBxNjA2enktbEVvdXhqdVJCOFM5bXZzOWEzYVJ1XzVFM0MxRS1iVVJwRWRoOVc5WVRTY2dTREFrZjJNTjNMUTlwZS1JOVM5bGtFaVFFSE1nSUU4dk5Ydks1cDFadC1TbmU0Z0ZwbmlmQm5lVm52Wk02S2…
Nuveen Real Asset Income and Growth Fund (JRI) Pulls Back 1.15% as Price Nears Support - OBV Trend Line - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMi_wFBVV95cUxNbXFpUmJPaGZIaGJ1cUdNX2ZDM3FFN29MNjBtUWJUbDYxYkYwM2MwOVBWUTVERjQ0QklfY0xYV0htQzV2V2JMTk9heWRabE1hdEJkVWlMQzk5UkRfTHlsalM3b214MWFWYXFBOS04UFl3VUpKT1V3bWxSNnRtTmYyNnk5MEVockhsdkxxTj…
JRI — Frequently Asked Questions
What is the current share price of JRI?
As of 2026-10-23 16:27 PDT, JRI trades at $10.75 on NASDAQ/NYSE. Its 52-week range is $10.27 to $12.61.
What is the market capitalisation of JRI?
JRI has a market capitalisation of $297.73M on NASDAQ/NYSE.
What is the P/E ratio of JRI?
JRI trades at a trailing price-to-earnings (P/E) ratio of 6.10. Its price-to-book (P/B) ratio is 0.81.
What is the return on equity (ROE) of JRI?
JRI has a return on equity (ROE) of 13.38%.
Is JRI a good stock to buy?
This page provides a data-driven analysis of JRI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.